190 related articles for article (PubMed ID: 29660685)
1. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease.
Dengler-Crish CM; Ball HC; Lin L; Novak KM; Cooper LN
Neurobiol Aging; 2018 Jul; 67():148-158. PubMed ID: 29660685
[TBL] [Abstract][Full Text] [Related]
2. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
Dengler-Crish CM; Smith MA; Wilson GN
J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
[TBL] [Abstract][Full Text] [Related]
3. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signaling in Alzheimer's disease.
De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
[TBL] [Abstract][Full Text] [Related]
7. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
8. An appropriate Wnt/β-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice.
Bao Q; Chen S; Qin H; Feng J; Liu H; Liu D; Li A; Shen Y; Zhao Y; Li J; Zong Z
Sci Rep; 2017 Jun; 7(1):2695. PubMed ID: 28578392
[TBL] [Abstract][Full Text] [Related]
9. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.
Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ
Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389
[TBL] [Abstract][Full Text] [Related]
10. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway.
Hu Y; Chen W; Wu L; Jiang L; Liang N; Tan L; Liang M; Tang N
J Mol Neurosci; 2019 Jan; 67(1):142-149. PubMed ID: 30539409
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.
Riise J; Plath N; Pakkenberg B; Parachikova A
J Neural Transm (Vienna); 2015 Sep; 122(9):1303-18. PubMed ID: 25680440
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis].
Wang Y; Liu Y; Ma JX; Li BX; Li YK
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):769-72. PubMed ID: 22321352
[TBL] [Abstract][Full Text] [Related]
15. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
[TBL] [Abstract][Full Text] [Related]
17. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice.
Li J; Bao Q; Chen S; Liu H; Feng J; Qin H; Li A; Liu D; Shen Y; Zhao Y; Zong Z
J Orthop Res; 2017 Apr; 35(4):812-819. PubMed ID: 27306622
[TBL] [Abstract][Full Text] [Related]
18. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
Rossini M; Gatti D; Adami S
Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
[TBL] [Abstract][Full Text] [Related]
19. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
20. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
